Individualized breast cancer screening catches more cancer

Individualized breast cancer screening catches more cancer
A breast cancer screening program tailored to participants' individual risk profiles has a higher-than-expected breast cancer detection rate in 40- to 49-year old women, according to a pilot study published in the August issue of Radiology.

(HealthDay)—A breast cancer screening program tailored to participants' individual risk profiles has a higher-than-expected breast cancer detection rate in 40- to 49-year old women, according to a pilot study published in the August issue of Radiology.

Elena Venturini, M.D., from San Raffaele Scientific Institute in Milan, invited 3,017 40- to 49-year-old women to participate in a breast cancer screening program tailored to lifetime risk (Gail test) and mammographic density (according to Breast Imaging Reporting and Data Systems [BI-RADS] criteria) with supplemental ultrasonography (US) or (MRI) and bilateral two-view microdose mammography.

The researchers found that among the 1,666 participating women, average lifetime risk of breast cancer was 11.6 percent, with nine women having a high risk of breast cancer and 917 women (55.0 percent) having a high-density score (BI-RADS density category 3 or 4). For screening examinations, the average glandular dose was 1.49 mGy. In 835 participants (50.1 percent), screening US was performed, mostly due to high (800 of 1,666 women). Nine women at high risk for breast cancer had screening MRI. Fourteen women were diagnosed with breast cancer (8.4 cases per 1,000 women). Microdose mammography was used to make 12 diagnoses, while two were made with supplemental US in (2.4 cases per 1,000 women). All cases had surgery, with pathologic analysis diagnosing four ductal carcinomas in situ and 10 invasive carcinomas (five at stage I).

"A tailored program in 40- to 49-year-old women yielded a greater-than-expected number of cancers, most of which were low-stage disease," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Old cancer drug could have new use in fighting cancer

date 2 hours ago

A drug used for decades to treat leukemia may have other uses in the fight against cancer, researchers at the University of Missouri have found. Previously, doctors used 6-Thioguanine, or 6-TG, as a chemotherapy ...

Cancer prevention efforts in the US a mixed bag

date 14 hours ago

While there has been substantial progress in some cancer control efforts in the past several decades, like reductions in smoking and increased utilization of cancer screening, progress in some areas is lagging, according ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.